Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market

Eterna Therapeutics (ERNA) Stock Price & Analysis

213 Followers

ERNA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.90 - $15.60
Previous Close$2.17
Volume33.48K
Average Volume (3M)22.55K
Market Cap
$11.44M
Enterprise Value$7.05M
Total Cash (Recent Filing)$5.40M
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)-0.4
Beta1.52
Apr 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.72
Shares Outstanding5,270,072
10 Day Avg. Volume99,590
30 Day Avg. Volume22,554
Standard Deviation1.63
R-Squared0.02
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue111.87
Enterprise Value/Gross Profit83.91
Enterprise Value/Ebitda-0.35
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ERNA FAQ

What was Eterna Therapeutics’s price range in the past 12 months?
Eterna Therapeutics lowest stock price was $1.90 and its highest was $15.60 in the past 12 months.
    What is Eterna Therapeutics’s market cap?
    Currently, no data Available
    When is Eterna Therapeutics’s upcoming earnings report date?
    Eterna Therapeutics’s upcoming earnings report date is Apr 14, 2023 which is 49 days ago.
      How were Eterna Therapeutics’s earnings last quarter?
      Eterna Therapeutics released its earnings results on Nov 08, 2022. The company reported -$2.488 earnings per share for the quarter, missing the consensus estimate of -$2.2 by -$0.288.
        Is Eterna Therapeutics overvalued?
        According to Wall Street analysts Eterna Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Eterna Therapeutics pay dividends?
          Eterna Therapeutics does not currently pay dividends.
          What is Eterna Therapeutics’s EPS estimate?
          Eterna Therapeutics’s EPS estimate is -$2.4.
            How many shares outstanding does Eterna Therapeutics have?
            Eterna Therapeutics has 5,270,072 shares outstanding.
              What happened to Eterna Therapeutics’s price movement after its last earnings report?
              Eterna Therapeutics reported an EPS of -$2.488 in its last earnings report, missing expectations of -$2.2. Following the earnings report the stock price went up 3.67%.
                Which hedge fund is a major shareholder of Eterna Therapeutics?
                Currently, no hedge funds are holding shares in ERNA

                ---

                Eterna Therapeutics Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -82.33%
                12-Months-Change

                Fundamentals

                Return on Equity
                -167.02%
                Trailing 12-Months
                Asset Growth
                -57.29%
                Trailing 12-Months
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Eterna Therapeutics

                NTN Buzztime, Inc. engages in the provision of entertainment and innovative technology services. It offers entertainment, live events, dining, marketing, hardware, and pricing products. It also includes performance analytics and secure payment with Europay, MasterCard, and Visa chip readers or with near-field communication (NFC) technology to accept Apple, Android, and Samsung Pay. The company was founded in 1984 and is headquartered in Carlsbad, CA.

                ---

                Top 5 ETFs holding ERNA

                Name
                Market Value
                Smart Score
                iShares Core S&P Total U.S. Stock Market ETF
                $2.00K
                8
                Up to five ETFs with an Outperform Smart Score that hold ERNA. The ETFs are listed according to market value of ERNA within the ETF

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                G1 Therapeutics
                Adverum Biotechnologies
                Ultragenyx Pharmaceutical
                RegenXBio

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis